Margaret Hamburg, M.D.
Co-president, InterAcademy Partnership
NTI board member Margaret A. Hamburg, MD, is joining NTI’s leadership to serve as interim vice president of the NTI | bio program in February. Hamburg, an internationally recognized leader in public health and medicine, replaces Beth Cameron, PhD, who has moved to the White House to rebuild the National Security Council’s Office of Global Health Security and Biodefense and advance the Biden Administration’s agenda on global health security.
Hamburg’s relationship with NTI goes back to its launch in 2001, when she was named as the organization’s founding senior scientist and biological program vice president. She went on to become commissioner of the Food and Drug Administration and foreign secretary of the National Academy of Medicine.
Hamburg joined NTI’s Board of Directors in 2017.
Sign up for our newsletter to get the latest on nuclear and biological threats.
Nuclear Threat Initiative (NTI) and Coalition for Epidemic Preparedness Innovations (CEPI) launch the Bio Funders Compact to safeguard rapidly advancing life science research and development.
Amid rapid advances at the intersection of artificial intelligence and the life sciences, NTI | bio and more than 25 leading experts took important steps toward creating a roadmap for safeguarding AI-enabled tools for engineering living systems from misuse.
NTI | bio will bring a 2024 Next Generation Biosecurity Delegation of early-career professionals to the Biological Weapons Convention (BWC) meetings from August 19 – 23.